Therapeutic Potential of Cyanobacteria as a Producer of Novel Bioactive Compounds

A Mini Review on Biotechnological Potentials of Bioactive Compounds and Bioproducts Isolated from Cyanobacteria

“…Cyanobacteria are among the most powerful and unconventional sources of drugs against many diseases (Swain et al, 2015). Many bioactive metabolites have been isolated from cyanobacteria, which have demonstrated the potential for further more drug exploration (Mazard et Yadav et al, 2023). Many secondary metabolites are produced by large multienzyme complexes, usually either nonribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or PKS-NRPS hybrids, where large multienzyme complexes modify and assemble individual peptides into a single active molecule (Welker et al, 2012).…”

“…Many secondary metabolites are produced by large multienzyme complexes, usually either nonribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or PKS-NRPS hybrids, where large multienzyme complexes modify and assemble individual peptides into a single active molecule (Welker et al, 2012). Cyanobacteria produce a wide range of bioactive compounds such as polyketides, polysaccharides, alkaloids, lipids, carotenes, fatty acids, vitamins, phycocyanin, and proteins, which possess many characteristics such as antiviral, antifungal, antibacterial, algicidal, anti-inflammatory, anti-aging, and anticancer activity (Mimouni et al, 2012;Demay et al, 2019;Verma et al, 2022;Yadav et al, 2023). Cyanobacteria include many different orders, with filamentous and colonial cyanobacteria being among the most productive sources of natural products (Mazard et al, 2016).…”